Somewhat Positive Media Coverage Somewhat Unlikely to Affect CAS Medical Systems (CASM) Stock Price

News articles about CAS Medical Systems (NASDAQ:CASM) have been trending somewhat positive this week, according to Accern. Accern identifies negative and positive media coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. CAS Medical Systems earned a daily sentiment score of 0.02 on Accern’s scale. Accern also assigned news articles about the medical technology company an impact score of 47.1203928998456 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

CAS Medical Systems (NASDAQ:CASM) opened at $1.03 on Wednesday. The company has a market capitalization of $29.07, a P/E ratio of -3.96 and a beta of -1.18. The company has a current ratio of 2.46, a quick ratio of 2.12 and a debt-to-equity ratio of -0.56. CAS Medical Systems has a 52-week low of $0.59 and a 52-week high of $1.75.

CAS Medical Systems (NASDAQ:CASM) last released its quarterly earnings results on Thursday, November 9th. The medical technology company reported ($0.01) EPS for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.05. The business had revenue of $4.53 million for the quarter, compared to the consensus estimate of $4.47 million. equities research analysts forecast that CAS Medical Systems will post -0.28 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This piece of content was posted by Community Financial News and is the property of of Community Financial News. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of international copyright legislation. The correct version of this piece of content can be accessed at

About CAS Medical Systems

CAS Medical Systems, Inc is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products for patient care. The Company designs, manufactures and distributes the FORE-SIGHT and FORE-SIGHT ELITE brand tissue oximeters and sensors. It operates through Tissue Oximetry Monitoring, which includes sales of its FORE-SIGHT tissue oximeter monitors, sensors and accessories.

Insider Buying and Selling by Quarter for CAS Medical Systems (NASDAQ:CASM)

Receive News & Ratings for CAS Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CAS Medical Systems and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit